...
首页> 外文期刊>Vaccine >PLGA encapsulated inactivated-viral vaccine: Formulation and evaluation of its protective efficacy against viral haemorrhagic septicaemia virus (VHSV) infection in olive flounder (Paralichthys olivaceus) vaccinated by mucosal delivery routes
【24h】

PLGA encapsulated inactivated-viral vaccine: Formulation and evaluation of its protective efficacy against viral haemorrhagic septicaemia virus (VHSV) infection in olive flounder (Paralichthys olivaceus) vaccinated by mucosal delivery routes

机译:PLGA包封的灭活病毒疫苗:对粘膜输送途径接种疫苗(Paralichthys Olivaceus)的病毒出血败血症病毒(VHSV)感染的保护性和评价

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Viral haemorrhagic septicaemia virus (VHSV), an OIE listed viral pathogen, is the etiological agent of a contagious disease, causing huge economic losses in farmed olive flounder (Paralichthys olivaceus) and significant mortalities among several other marine fish species in Korea, Japan, and China. In continuation with our previous work, where injection vaccination with inactivated VHSV mixed with squalene (as adjuvant) conferred higher protective immunity to olive flounder, the present study focused on replacing the injection route of vaccine delivery by immersion/oral route to overcome the limitations of the par enteral immunization method. Here, we encapsulated the inactivated VHSV vaccine with PLGA (poly lactic-co-glycolic acid) nanoparticles (PNPs-IV) and evaluated its ability to induce protective immunity in olive flounder (12.5 +/- 1.5 g) by initially immunizing the fishes by immersion route followed by a booster with the same dose two weeks later with half of the fish through immersion route and other half through oral route (incorporated into fish feed). Cumulative mortalities post-challenge (1 x 10(6) TCID50 virus/fish) with virulent VHSV-isolate, were lower in vaccinated fish and RPS of 60% and 73.3% were obtained for PNPs-IV (immersion/immersion) and PNPs-IV (immersion/oral) groups, respectively. In addition, specific (anti-VHSV) antibody titre in the fish sera, skin mucus and intestinal mucus of the immunized groups were significantly (p & 0.05) enhanced following vaccination. Furthermore, PNPs-IV immunized fish showed significant (p & 0.05) upregulation of different immune gene transcripts (IgM, IgT, plgR, MHC-I, MHC-II, IFN-gamma, and Caspase3) compared to controls, in both the systemic (kidney) and mucosal (skin and intestine) immune compartment of the host post immunization as well as post challenge. Thus it can be inferred that the adopted immunization strategy efficiently protected and transported the inactivated viral antigen to target immune organs and positively stimulated the protective immune response against VHSV in olive flounder. (C) 2019 Elsevier Ltd. All rights reserved.
机译:病毒出血性败血症病毒(VHSV)是一个oie上市的病毒病原体,是一种传染病的病因,导致养殖橄榄鼠(Paralichthys Olivaceus)的巨大经济损失以及韩国,日本其他几个海洋鱼类中的大量死亡人数。中国。在继续与我们之前的作品中,其中用灭活的VHSV与Squalene(作为佐剂)混合的注射疫苗接种赋予橄榄蝇的较高的保护性免疫,本研究重点是通过浸没/口腔途径替代疫苗递送的注射途径,以克服局限性探针免疫法。在这里,我们将灭活的VHSV疫苗与PLGA(聚乳酸 - 共乙醇酸)纳米颗粒(PNPS-IV)封装,并评估其通过最初通过初始免疫鱼类(12.5 +/- 1.5g)诱导橄榄絮凝物(12.5 +/- 1.5g)中的保护性免疫的能力浸没途径随后是两周后用同一剂量的增强剂,通过浸渍途径和其他一半通过口腔途径(掺入鱼饲料)。患有毒性VHSV隔离物的累积死亡率(1 x 10(6)个TCID50病毒/鱼类),接种疫苗的鱼类和60%和73.3%的RPS用于PNPS-IV(浸渍/浸渍)和PNPS- IV(浸没/口服)组分别。此外,免疫基团的鱼血清中的特异性(抗VHSV)抗体滴度显着(P& 0.05),在接种后增强。此外,与对照相比,PNPS-IV免疫鱼显示出显着的(P& 0.05)升高(P& 0.05)不同免疫基因转录物(IgM,IgT,PlgR,MHC-I,MHC-II,IFN-γ和Caspase3)。全身(肾脏)和粘膜(皮肤和肠道)免疫接种后的免疫室和攻击后的免疫室。因此,可以推断采用的免疫策略有效地保护并将灭活的病毒抗原靶向免疫器官,并积极刺激对橄榄野生血鼠的保护性免疫应答。 (c)2019 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号